Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MIF | P14174 | 6/20 | 0.36 |
| ▸ | PPM1B | O75688 | 1/20 | 0.36 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.36 |
| ▸ | PPP1CC | P36873 | 1/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | GLA | P06280 | 1/20 | 0.31 |
| ▸ | NPC1 | O15118 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
| ▸ | RAB9A | P51151 | 1/20 | 0.30 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25061706 | 0.89 | MIF (0.35) | MIFPPM1BPTPN1PPP1CCCYP1A2 | |
| SCHEMBL25061570 | 0.88 | ALDH1A1 (0.35) | MIFPPM1BPTPN1PPP1CCCYP1A2 | |
| SCHEMBL20640947 | 0.80 | MIF (0.50) | MIFCYP1A2CYP2C19HTTKDM4E | |
| SCHEMBL25061719 | 0.78 | MIF (0.36) | MIFHTTNPC1HPGDRAB9A | |
| SCHEMBL25061491 | 0.77 | MIF (0.35) | MIFCYP1A2CYP2C19HTTNPC1 | |
| SCHEMBL25400433 | 0.72 | CAPN9 (0.32) | MIFKDM4ENPC1HPGDRAB9A | |
| SCHEMBL25400440 | 0.72 | CAPN9 (0.32) | MIFKDM4ENPC1HPGDRAB9A | |
| Hydrochloric Acid SCHEMBL25398147 | 0.71 | CAPN9 (0.31) | MIFKDM4ENPC1HPGDRAB9A | |
| Hydrochloric Acid SCHEMBL25398149 | 0.71 | CAPN9 (0.31) | MIFKDM4ENPC1HPGDRAB9A | |
| SCHEMBL20640508 | 0.70 | MLYCD (0.32) | CYP1A2CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230053699-A1 | SUBSTITUTED-ISOXAZOLINE-CONTAINING AROMATIC COMPOUND, PREPARATION METHOD THEREFOR, HERBICIDAL COMPOSITION AND USE THEREOF | QINGDAO KINGAGROOT CHEMICAL COMPOUND CO., LTD. (CN) | 2023-02-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230053699-A1 | SUBSTITUTED-ISOXAZOLINE-CONTAINING AROMATIC COMPOUND, PREPARATION METHOD THEREFOR, HERBICIDAL COMPOSITION AND USE THEREOF | CYP4X1, CYP4F11, CBR3 | MIF 4762/4885PPM1B 2241/4885PTPN1 1552/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.